Cargando…
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
BACKGROUND: Free circulating DNA (fcDNA) has many potential clinical applications, due to the non-invasive way in which it is collected. However, because of the low concentration of fcDNA in blood, genome-wide analysis carries many technical challenges that must be overcome before fcDNA studies can...
Autores principales: | Warton, Kristina, Lin, Vita, Navin, Tina, Armstrong, Nicola J, Kaplan, Warren, Ying, Kevin, Gloss, Brian, Mangs, Helena, Nair, Shalima S, Hacker, Neville F, Sutherland, Robert L, Clark, Susan J, Samimi, Goli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078241/ https://www.ncbi.nlm.nih.gov/pubmed/24929644 http://dx.doi.org/10.1186/1471-2164-15-476 |
Ejemplares similares
-
Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015) -
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
por: Warton, Kristina, et al.
Publicado: (2016) -
ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
por: Gloss, Brian, et al.
Publicado: (2014) -
Multiplex bisulfite PCR resequencing of clinical FFPE DNA
por: Korbie, Darren, et al.
Publicado: (2015) -
The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020)